Klabuzai, Á.; Bekő, V.; Sütő, Z.; Horváth, M.; Wágner, Z.; Vágási, K.; Pfeil, V.; Süle, M.; Grosz, G.; Wittmann, I.;
et al. The Impact of SGLT-2 Inhibitors on Hydroxyl Radical Markers and Diabetic Neuropathy: A Short-Term Clinical Study. Antioxidants 2025, 14, 289.
https://doi.org/10.3390/antiox14030289
AMA Style
Klabuzai Á, Bekő V, Sütő Z, Horváth M, Wágner Z, Vágási K, Pfeil V, Süle M, Grosz G, Wittmann I,
et al. The Impact of SGLT-2 Inhibitors on Hydroxyl Radical Markers and Diabetic Neuropathy: A Short-Term Clinical Study. Antioxidants. 2025; 14(3):289.
https://doi.org/10.3390/antiox14030289
Chicago/Turabian Style
Klabuzai, Ágnes, Viktória Bekő, Zsófia Sütő, Marcell Horváth, Zoltán Wágner, Katalin Vágási, Veronika Pfeil, Miklós Süle, György Grosz, István Wittmann,
and et al. 2025. "The Impact of SGLT-2 Inhibitors on Hydroxyl Radical Markers and Diabetic Neuropathy: A Short-Term Clinical Study" Antioxidants 14, no. 3: 289.
https://doi.org/10.3390/antiox14030289
APA Style
Klabuzai, Á., Bekő, V., Sütő, Z., Horváth, M., Wágner, Z., Vágási, K., Pfeil, V., Süle, M., Grosz, G., Wittmann, I., & Kun, S.
(2025). The Impact of SGLT-2 Inhibitors on Hydroxyl Radical Markers and Diabetic Neuropathy: A Short-Term Clinical Study. Antioxidants, 14(3), 289.
https://doi.org/10.3390/antiox14030289